Compound class:
Synthetic organic
Comment: Chinfloxacin is a synthetic tricyclic fluoroquinolone antibacterial [1]. Its chemical structure is similar to that of moxifloxacin.
|
|
No information available. |
Summary of Clinical Use ![]() |
Chinfloxacin completed first-in-human trial in healthy subjects with results published in 2018 [2]. Its pharmacokinetics supported once-daily dosing. |